Karo Pharma Aktiebolag is an innovative drug discovery and development company specializing in the development of novel pharmaceuticals that target nuclear receptors. Nuclear receptors are also known as transcription factors and may be regarded as on/off buttons for production of proteins, such as enzymes and receptors. The nuclear receptors control biological processes at their core level, the genetic level. The natural hormones exert the body's own very tight control of protein production. By targeting nuclear receptors, Co. tunes the body's own control systems, for instance to normalize the metabolism of lipids in patients with elevated blood cholesterol.
Ford US Equity Research covers more than 4,000 stocks using a proprietary quantitative model that evaluates a company’s earnings strength, its relative valuation and recent price movement. Ford’s five recommendation ratings include strong buy, buy, hold, sell, strong sell. For all stocks in our coverage universe, ratings are generated each week and reflect the fundamental and price data as of the last trading day of the week.
Ford Equity International Research Reports cover 60 countries with over 30,000 stocks traded on international exchanges. A proprietary quantitative system compares each company to its peers on proven measures of business value, growth characteristics, and investor behavior. Ford's three recommendation ratings buy, hold and sell, represent each stock’s return potential relative to its own country market.. The rating reports which are generated each week, include the fundamental details behind each recommendation and reflect the fundamental and price data as of the last trading day of the week.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.